Target Price | $336.60 |
Price | $309.88 |
Potential | 8.62% |
Number of Estimates | 48 |
48 Analysts have issued a price target Zscaler, Inc. 2026 . The average Zscaler, Inc. target price is $336.60. This is 8.62% higher than the current stock price. The highest price target is $404.25 30.45% , the lowest is $217.15 29.92% . | |
A rating was issued by 56 analysts: 43 Analysts recommend Zscaler, Inc. to buy, 13 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Zscaler, Inc. stock has an average upside potential 2026 of 8.62% . Most analysts recommend the Zscaler, Inc. stock at Purchase. |
52 Analysts have issued a sales forecast Zscaler, Inc. 2026 . The average Zscaler, Inc. sales estimate is $3.4b . This is 26.33% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $3.5b 31.53% , the lowest is $3.2b 19.75% .
This results in the following potential growth metrics:
2025 | $2.7b | 23.31% |
---|---|---|
2026 | $3.4b | 26.33% |
2027 | $4.0b | 19.66% |
2028 | $4.8b | 18.93% |
2029 | $5.8b | 20.37% |
2030 | $6.9b | 18.96% |
2031 | $8.1b | 18.41% |
2032 | $9.6b | 17.87% |
22 Analysts have issued an Zscaler, Inc. EBITDA forecast 2026. The average Zscaler, Inc. EBITDA estimate is $886m . This is 836.02% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $938m 879.35% , the lowest is $807m 770.57% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $-122m | 1.64% |
---|---|---|
2026 | $886m | 828.10% |
2027 | $1.1b | 23.25% |
2028 | $1.3b | 23.17% |
2025 | -4.55% | 17.58% |
---|---|---|
2026 | 26.24% | 676.40% |
2027 | 27.02% | 2.97% |
2028 | 27.99% | 3.59% |
51 Zscaler, Inc. Analysts have issued a net profit forecast 2026. The average Zscaler, Inc. net profit estimate is $600m . This is 1,546.50% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $710m 1,811.04% , the lowest is $565m 1,460.97% .
This results in the following potential growth metrics and future Net Margins:
2025 | $-41.5m | 28.12% |
---|---|---|
2026 | $600m | 1,546.50% |
2027 | $722m | 20.35% |
2028 | $885m | 22.48% |
2029 | $1.1b | 28.67% |
2030 | $1.4b | 24.14% |
2031 | $1.9b | 33.18% |
2032 | $2.4b | 29.55% |
2025 | -1.55% | 41.71% |
---|---|---|
2026 | 17.77% | 1,245.16% |
2027 | 17.87% | 0.56% |
2028 | 18.40% | 2.97% |
2029 | 19.67% | 6.90% |
2030 | 20.53% | 4.37% |
2031 | 23.09% | 12.47% |
2032 | 25.38% | 9.92% |
51 Analysts have issued a Zscaler, Inc. forecast for earnings per share. The average Zscaler, Inc. EPS is $3.79 . This is 1,503.70% higher than earnings per share in the financial year 2025. The highest EPS forecast is $4.48 1,759.26% , the lowest is $3.57 1,422.22% .
This results in the following potential growth metrics and future valuations:
2025 | $-0.27 | 30.77% |
---|---|---|
2026 | $3.79 | 1,503.70% |
2027 | $4.56 | 20.32% |
2028 | $5.59 | 22.59% |
2029 | $7.19 | 28.62% |
2030 | $8.92 | 24.06% |
2031 | $11.89 | 33.30% |
2032 | $15.40 | 29.52% |
Current | -1,147.70 | 163.95% |
---|---|---|
2026 | 81.76 | 107.12% |
2027 | 67.93 | 16.92% |
2028 | 55.46 | 18.36% |
2029 | 43.10 | 22.29% |
2030 | 34.72 | 19.44% |
2031 | 26.07 | 24.91% |
2032 | 20.12 | 22.82% |
Analyst | Rating | Action | Date |
---|---|---|---|
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Oct 02 2025 |
Canaccord Genuity |
Buy
➜
Buy
|
Unchanged | Sep 04 2025 |
BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Sep 03 2025 |
Guggenheim |
Neutral
➜
Neutral
|
Unchanged | Sep 03 2025 |
Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Sep 03 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Sep 03 2025 |
Baird |
Outperform
➜
Outperform
|
Unchanged | Sep 03 2025 |
Analyst Rating | Date |
---|---|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Oct 02 2025 |
Unchanged
Canaccord Genuity:
Buy
➜
Buy
|
Sep 04 2025 |
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Sep 03 2025 |
Unchanged
Guggenheim:
Neutral
➜
Neutral
|
Sep 03 2025 |
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Sep 03 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Sep 03 2025 |
Unchanged
Baird:
Outperform
➜
Outperform
|
Sep 03 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.